Close
Digital Health & Ai Innovation summit 2026
APE 2026

Hocoma launches a new version of its established gait training device LokomatPro

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA Gives Clearance to Hugo RAS...

Medtronic, which is a global leader when it comes...

FDA May Scrutinize Medical Device Cybersecurity...

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare...

Pristina Recon DL tool from GE HealthCare which uses...
Since the launch of Hocoma’s first gait therapy device in 2001, the LokomatPro has established itself as an effective intervention for improving over-ground walking function in patients who suffer of neurological diseases and injuries resulting in gait impairment. In strong collaboration with clinical research partners, Hocoma has now developed a new and more compact version of the LokomatPro. The new version of the LokomatPro has been developed with the needs of patients and clinics in mind and provides extensive locomotion therapy to help patients trigger great improvements.

It features a new and more compact design and is equipped with the Augmented Feedback and a touch screen as a standard. In the future, upgrading options (e.g. additional degrees of freedom at the hip joint, sophisticated control strategy, higher gait speed) will extend the LokomatPro as a sophisticated gait training device supporting the therapists and the patients in reaching their therapy goals. As the preceding versions, with the optional Pediatric Orthoses, the LokomatPro provides intensive locomotion therapy also for the treatment of children with cerebral palsy or other neurological disorders.

Latest stories

Related stories

FDA Gives Clearance to Hugo RAS System, Confirms Medtronic

Medtronic, which is a global leader when it comes...

FDA May Scrutinize Medical Device Cybersecurity More in 2026

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare Receives a PMA

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker for Around $21 Billion

In a recent move, Abbott has gone ahead and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »